NOVARTIS
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Their mission is to discover new ways to improve and extend people's lives. They apply their expertise in science and innovation to society’s biggest health challenges. Responsibility is a core part of their business strategy.
NOVARTIS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1996-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.novartis.com
Total Employee:
10001+
Status:
Active
Contact:
+41 61 324 11 11
Email Addresses:
[email protected]
Total Funding:
6.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
Abomics
Abomics Ltd is an expert company that promotes the application of medical research to patient care.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Antidote.me
Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Vero Biotech
Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.
MedCompared
MedCompared is a health comparison site that helps you to choose your prescribed medication for the best price in the best online pharmacy.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Novartis India
Novartis India is a healthcare company that address needs and deliver better patient outcomes.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
PharmaLead
PharmaLead is a healthcare company that advises and improves pharmacies in the re-design of business processes and business operations.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-12-22 | Gyroscope Therapeutics | Gyroscope Therapeutics acquired by Novartis | 1.5 B USD |
2021-09-17 | Arctos Medical | Arctos Medical acquired by Novartis | N/A |
2021-06-01 | Cellerys | Cellerys acquired by Novartis | N/A |
2020-12-17 | Cadent Therapeutics | Cadent Therapeutics acquired by Novartis | 770 M USD |
2020-10-29 | Vedere Bio ll | Vedere Bio ll acquired by Novartis | 280 M USD |
2020-04-20 | Amblyotech | Amblyotech acquired by Novartis | N/A |
2019-11-24 | The Medicines Company | The Medicines Company acquired by Novartis | 9.7 B USD |
2019-05-09 | Xiidra | Xiidra acquired by Novartis | 1.9 B USD |
2018-12-21 | CellforCure | CellforCure acquired by Novartis | N/A |
2018-10-18 | Endocyte | Endocyte acquired by Novartis | N/A |
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Novartis
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-25 | Aktis Oncology | Novartis investment in Series A - Aktis Oncology | 84 M USD |
2022-07-25 | Cleerly | Novartis investment in Series C - Cleerly | 223 M USD |
2022-06-22 | Alladapt Immunotherapeutics | Novartis investment in Venture Round - Alladapt Immunotherapeutics | 119 M USD |
2022-05-19 | Deciphex | Novartis investment in Series B - Deciphex | 11.5 M USD |
2022-03-04 | Klarah | Novartis investment in Grant - Klarah | 20 K USD |
2022-03-04 | Parrots | Novartis investment in Pre Seed Round - Parrots | 100 K USD |
2021-12-07 | Freenome | Novartis investment in Series D - Freenome | 300 M USD |
2021-12-06 | Holmusk | Novartis investment in Venture Round - Holmusk | N/A |
2021-12-02 | Medtech Africa | Novartis investment in Grant - Medtech Africa | 20 K USD |
2021-11-09 | Mekonos | Novartis investment in Series A - Mekonos | 25 M USD |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.novartis.com Semrush global rank: 104.19 K Semrush visits lastest month: 941 K
- Host name: 104.18.0.16
- IP address: 104.18.0.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novartis" on Search Engine
Novartis announces new organizational structure to accelerate …
Apr 04, 2022. Ad hoc announcement pursuant to Art. 53 LR. New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity. Integrating Pharmaceuticals and Oncology business units into an Innovative Medicines (IM) …See details»
Novartis organizational structure
Novartis organizational structure Last updated: May 2024 ECN Members. Kees Roks. Chief Audit Officer. Michelle Weese. Chief Corporate Affairs Officer. Rob Kowalski. Chief People & Organization Officer . Klaus Moosmayer. Chief Ethics, Risk & Compliance Officer. Fiona H. Marshall. President, Biomedical Research. Harry Kirsch. Chief Financial ...See details»
About | Novartis
Our strategy. Deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. Our footprint. 78k. Employees. 140+. Nationalities. 284m. Patients reached. Download the Novartis in Society Integrated Report 2023 for more details (PDF 8.4 MB)See details»
Company overview | Novartis
About Novartis. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.See details»
Novartis - Wikipedia
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in …See details»
Reporting and transparency hub | Novartis
These reports provide a comprehensive overview of Novartis, including our company structure, corporate governance, operating and financial results, and compensation practices. They are filed with the SIX Swiss Exchange in Switzerland and the Securities and Exchange Commission in the US.See details»
Who we are - Novartis Annual Review 2020
Our purpose. We reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.See details»
Novartis announces new organizational structure - World Pharma …
05 April 2022. Novartis announced the introduction of a new organizational structure and operating model designed to support the company’s innovation, growth, and productivity ambitions as a focused medicines company in the coming decade.See details»
The Culture And Leadership Code Of Novartis - Forbes
Jan 20, 2021 To learn more about how Novartis scales leadership development as a sales powerhouse, I spoke with Alison Pulte, associate director of leadership development for Novartis’ U. S.-based first- and ...See details»
Novartis: An Introduction to Organization Structure | Technology ...
Novartis: An Introduction to Organization Structure | Technology Strategy | Sloan School of Management | MIT OpenCourseWare. Lecture Notes. Novartis: An Introduction to Organization Structure. Description: Lecture presentation on with an introduction to organization structure, value creation, and the case of Novartis. Resource Type: …See details»
Novartis announces changes to the Executive Committee
Basel, May 16, 2018 - Novartis announced today that Felix R. Ehrat, Group General Counsel of Novartis, has decided to retire from the company. Shannon Thyme Klinger, currently Chief Ethics, Risk and Compliance Officer, will be appointed Group General Counsel, effective June 1, 2018.See details»
Novartis announces new organizational structure to
Basel, April 4, 2022 — Novartis today announced the introduction of a new organizational structure and operating model designed to support the company’s innovation, growth, and productivity...See details»
Novartis' global revamp to cost thousands of jobs for simpler ...
By Angus Liu Apr 12, 2022 10:05am. Novartis layoffs restructuring job cuts. Because its goal is to have better efficiency through leaner structures, the company's new initiative will “inevitably...See details»
How Novartis Is Finding The Path To Be A Digital Winner - Forbes
Jul 31, 2022 A firm that is finding the right path is Novartis, a Swiss firm with over 100,000 employees that researches, develops, manufactures, and markets healthcare products in more than a hundred...See details»
Novartis - Crunchbase Company Profile & Funding
Organization. Novartis. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Novartis is a healthcare company that provides solutions to address the evolving needs of patients worldwide. Basel, Basel-Stadt, Switzerland. 10001+. Grant. Public. www.novartis.com. 3,404. Stock Symbol NYSE:NVS. Acquisitions 33.See details»
Global Health & Corporate Responsibility | Novartis
Jul 8, 2019 Novartis has transformed its Global Health & Corporate Responsibility (GH&CR) organization. The change consolidates and streamlines expertise and resources to achieve a stronger focus on the areas where the company can have the greatest impact.See details»
Novartis unveils major re-org - International Pharmaceutical Industry
Current Edition. Novartis unveils major re-org. Novartis has announced a new organizational structure and operating model, with an eye on innovation and growth — as well as targeted savings of at least $1 billion by 2024.See details»
AI closeup: Ashley Sardjoe of Novartis details how ChatGPT …
14 hours ago Canadian HR Reporter recently spoke with Novartis Canada’s Global People and Organization Leader, Ashley Sardjoe, about how he is using generative AI to make his life and job easier. “I will fully acknowledge that there is always a big FOMO on my end, because I do believe that there is so much more that I could use,” he says, …See details»
Novartis Foundation
Novartis Foundation. CARDIO4Cities Accelerator - Transforming Heart Health around the Globe. Learn more. Advancing digital and data-led approaches to population health. The Novartis Foundation focuses on the world’s most pressing health challenges: cardiovascular disease and health inequity.See details»
Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.See details»